Acurx Pharmaceuticals Inc (ACXP)
2.17
+0.05
(+2.36%)
USD |
NASDAQ |
May 03, 16:00
2.17
0.00 (0.00%)
After-Hours: 20:00
Acurx Pharmaceuticals Total Liabilities (Quarterly): 3.042M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.042M |
| September 30, 2023 | 3.223M |
| June 30, 2023 | 3.019M |
| March 31, 2023 | 2.074M |
| December 31, 2022 | 2.062M |
| September 30, 2022 | 1.182M |
| June 30, 2022 | 0.4739M |
| Date | Value |
|---|---|
| March 31, 2022 | 0.633M |
| December 31, 2021 | 0.8439M |
| September 30, 2021 | 0.7124M |
| June 30, 2021 | 1.919M |
| March 31, 2021 | 0.5107M |
| December 31, 2020 | 0.5224M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.4739M
Minimum
Jun 2022
3.223M
Maximum
Sep 2023
1.555M
Average
1.182M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp | 48.93M |
| Seelos Therapeutics Inc | 38.93M |
| PetVivo Holdings Inc | 2.735M |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.709M |
| Shareholders Equity (Quarterly) | 57.89M |